Wells Fargo raised the firm’s price target on Insulet (PODD) to $360 from $350 and keeps an Overweight rating on the shares. The firm notes the company posted a strong Q3 sales/EPS beat and raised FY25 guidance by more than 2-times the beat, mainly on U.S. growth.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PODD: